Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
T. Yi
Observed names:
Tian-Ci Yi,
Tianfei Yi,
Tianhao Yi,
Tuo Yi
Institution:
Southwestern University of Finance and Economics
Observed institutions:
Guizhou University,
Southwestern University of Finance and Economics,
Ningbo Center for Disease Control and Prevention,
Xiangyang Central Hospital
ORCID:
0009-0009-5053-5162
Observed ORCID:
0009-0009-5053-5162
OpenAlex ID:
A5112973256
Notch Signaling in Insect Development: A Simple Pathway with Diverse Functions
2023
·
Yao Chen
, Haomiao Li
, et al.
·
International Journal of Molecular Sciences
·
28
PDF
347MO The safety and efficacy of ivonescimab in combination with chemotherapy as first-line (1L) treatment for triple-negative breast cancer (TNBC)
2024
·
Q. Ouyang
, X. Wang
, et al.
·
Annals of Oncology
·
18
PDF
Evaluating electricity transmission and distribution efficiency using Data Envelopment Analysis Forest with feature importance
2025
·
Tianhao Yi
, Lisha Li
, et al.
·
Energy
·
5
HAEA: A heterogeneous alternating evolutionary algorithm for numerical optimization
2025
·
Taiyong Li
, Tianhao Yi
, et al.
·
Expert Systems with Applications
·
3
Standardization of case definition and development of early-warning model for acute respiratory infection syndromes based on Yinzhou Regional Health Information Platform
2025
·
Tianfei Yi
, Junfeng Zhang
, et al.
·
Frontiers in Public Health
·
3
PDF
Epigenetic-mediated positive feedback loop facilitates the progression of lung adenocarcinoma
2025
·
Yihang Cheng
, Yifeng Luo
, et al.
·
iScience
·
2
Immunogenic cell death-related genes as prognostic biomarkers and therapeutic insights in uterine corpus endometrial carcinoma: an integrative bioinformatics analysis
2025
·
Tianfei Yi
, Zhenglun Yang
, et al.
·
Frontiers in Oncology
·
2
EP08.02-063 SANOVO: A Phase 3 Study of Savolitinib or Placebo in Combination with Osimertinib in Patients with EGFR-mutant and MET Overexpressed NSCLC
2022
·
Q. Zhou
, J. Li
, et al.
·
Journal of Thoracic Oncology
·
2
PDF
P3.12.64 Frontline Treatment Duration in MET-Amplified NSCLC After Third-Generation EGFR-TKI Failure: SACHI Study Insights
2025
·
L. Chen
, S. Lu
, et al.
·
Journal of Thoracic Oncology
·
1
EP08.02-139 A Phase 2 Study of Befotertinib in Patients with EGFR T790M Mutated NSCLC after Prior EGFR TKIs
2022
·
S. Lu
, Y. Zhang
, et al.
·
Journal of Thoracic Oncology
·
1
An explainable heterogeneous graph convolutional neural network approach for investor preference analysis with online learning
2026
·
Xiao Hu
, Jingshen Zhao
, et al.
·
Applied Soft Computing
Safe Haven: The ESG Investment of Funds Under the Industry Contagion Risk
2026
·
Quansheng Xuan
, Tianhao Yi
, et al.
·
Accounting and Finance
Carbon Premium, Climate Policy Uncertainty and Asset Pricing in China
2026
·
Shan Chen
, Tianhao Yi
, et al.
·
Sustainability
PDF
MA17.08 Safety and Efficacy of Tifcemalimab Combined with Toripalimab in Refractory Extensive Stage Small Cell Lung Cancer
2024
·
Y. Cheng
, J. Wang
, et al.
·
Journal of Thoracic Oncology
PDF
Show more works
View as search
Works count:
14
Citation count:
65
H-index:
3
I10-index:
2
Year
Topic
Type